Nordion Supports Bruce Power Refurbishments to Secure Cobalt-60 Supply

Sterigenics International and Nordion welcome landmark agreement from Bruce Power and Ontario’s Independent Electricity System Operator to extend the life of six reactors, enabling continued long-term supply of Cobalt-60

Cobalt-60 is essential to the global healthcare community and this announcement showcases Ontario’s continued leadership in gamma sterilization

TORONTO – DEC. 4, 2015 – Sterigenics International LLC and subsidiary Nordion welcome the joint announcement from Bruce Power and Ontario’s Independent Electricity System Operator (IESO) to refurbish six of Ontario’s nuclear reactors…

New Agreement Seeks to Secure Critical Long Term Isotope Supply

Developing a new source of Cobalt-60 essential to global healthcare providers and patients

TORONTO – OCT. 27, 2015 – Two of Ontario’s innovative nuclear sector companies are once again building on their strong partnership and respective strengths to create a new, long-term supply of an important cancer-treating isotope, Cobalt-60, that will benefit healthcare patients in Canada and around the world…

Nordion welcomes Milestone Funding from National Nuclear Security Administration to Advance New Source of Medical Isotopes

Nordion welcomes Milestone Funding from National Nuclear Security Administration to Advance New Source of Medical Isotopes

Funding supports Nordion’s collaboration with General Atomics and the University of Missouri Research Reactor Center to produce a new, reliable source of medical isotopes

OTTAWA, Canada, September 30, 2015 – Nordion, a standalone business within Sterigenics International, welcomes today’s announcement by the United States Department of Energy’s (DOE) National Nuclear Security Administration (NNSA) to award $9.7M…

We are proud to announce the decision from the Canadian Nuclear Safety Commission (CNSC) to renew the Nuclear Substance Processing Facility Operating License for Nordion’s Class 1B nuclear substance processing facility in Ottawa, Ontario

Nordion welcomes 10 year operating license renewal

Canadian Nuclear Safety Commission approves ten-year license renewal for Ottawa, Ontario
nuclear substance processing facility

OTTAWA, Canada, September 30, 2015 — Nordion, a standalone business within Sterigenics International, today welcomed the Canadian Nuclear Safety Commission (CNSC) decision to renew the Nuclear Substance Processing Facility Operating License for the company’s Class 1B nuclear substance processing facility in Ottawa, Ontario…

A landmark partnership to establish a new, reliable supply of medical isotopes will enable Nordion to continue to serve millions of patients around the world well into the future. Read the press release.

Sterigenics International and Nordion announce landmark Canada-U.S. partnership agreement to provide a long-term, reliable supply of medical isotopes

New medical isotope supply agreements with U.S.-based MURR and General Atomics will serve patients in Canada, the U.S. and around the world.

OTTAWA (Feb 20, 2015) – – Sterigenics International LLC and subsidiary Nordion, announced today agreements with General Atomics and the University of Missouri Research Reactor Center (MURR®) to establish a new, reliable supply of medical isotopes…